Reappraisal of the efficacy of a simplified artesunate regimen in falciparum malaria
The Journal of Infectious Diseases, 07/09/2012
Woodrow CJ et al. – This means that the simplified artesunate regimen is very likely to be inferior to standard (around 9 chances in 10) with, it must be assumed, an accompanying likelihood of clinical detriment in the form of increased mortality. In this clearer light, omission of the 12–hour artesunate dose from the current regimen looks like a backward step for severe malaria treatment.